Liraglutide Generic Cost: What Patients Should Know Before Filling a Prescription

Generic liraglutide is FDA-approved as a generic referencing Victoza, a once-daily GLP-1 injection for type 2 diabetes. Your cost depends on the product prescribed, dose, pharmacy, insurance coverage, and discounts. Generic liraglutide is not the same as having a Saxenda-referencing generic for weight loss.

How much does generic liraglutide cost?

Generic liraglutide cost has no universal monthly price. The number changes with the prescribed product, dose, number of pens needed, insurance coverage, pharmacy contract, and whether discounts apply.

Quick facts: generic liraglutide, Victoza, and Saxenda

Liraglutide is the active ingredient in Victoza and Saxenda. Victoza is FDA-approved for type 2 diabetes, while Saxenda is FDA-approved for chronic weight management in adults with obesity or overweight with weight-related conditions, and in certain adolescents with obesity 2, 3.

The FDA-approved generic liraglutide injection references Victoza, not Saxenda 1. That matters because a pharmacy claim for diabetes can be handled very differently than a claim for weight management.

Why there is no single monthly price

• Your diagnosis and FDA-labeled indication can affect coverage.
• Your plan may require prior authorization before paying.
• Different pharmacies may show different cash prices.
• The dose and number of pens used in a month can change the refill quantity.
• Generic availability can vary by wholesaler and pharmacy.

The FDA notes that generic drugs can add treatment options and are generally more affordable, but that does not tell you your exact out-of-pocket cost at the register 1. A cost-effectiveness review in type 2 diabetes also found that modeled value depends heavily on assumptions, time horizon, and real-world use 4.

What changes the number of pens you may need

Liraglutide is supplied in multi-dose injection pens. The FDA-approved Victoza label describes once-daily dosing, starting at 0.6 mg daily for one week, then 1.2 mg daily, with a possible increase to 1.8 mg daily if more glycemic control is needed 2. This is label information, not personal dosing advice.

Saxenda’s FDA-approved weight-management label describes a higher target dose, titrated weekly from 0.6 mg daily to 3 mg daily 3. Because the labeled dose is different, the number of pens used per month can differ between diabetes and weight-management products.

Is liraglutide available as a generic?

Yes, liraglutide is available as an FDA-approved generic referencing Victoza. But that does not automatically mean there is a generic version referencing Saxenda for weight management.

What the FDA approved

The FDA approved the first generic referencing Victoza, liraglutide injection 18 mg/3 mL, for improving glycemic control in adults and children age 10 years and older with type 2 diabetes, as an adjunct to diet and exercise 1.

FDA-approved liraglutide generic vs authorized generic terminology

A true FDA-approved generic is reviewed through an abbreviated new drug application and must meet FDA standards for generic approval. An authorized generic is generally the brand drug marketed without the brand name, but it is not approved through the same generic application pathway 5.

Why a Victoza-referencing liraglutide generic does not automatically mean a Saxenda-referencing generic

Victoza and Saxenda share liraglutide as the active ingredient, but they have different labeled uses and dose schedules 2, 3. A generic referencing Victoza should not be described as a Saxenda-referencing product unless the FDA has approved it for that reference product.

What is liraglutide used for?

Liraglutide is used differently depending on the product. Victoza and generic liraglutide referencing Victoza are diabetes medications; Saxenda is a weight-management medication.

Victoza and generic liraglutide for type 2 diabetes

Victoza is FDA-approved to improve blood sugar control in adults and children age 10 and older with type 2 diabetes, as an add-on to diet and exercise 2. It is also approved to reduce the risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease 2.

Saxenda for chronic weight management

Saxenda is FDA-approved for chronic weight management in adults with obesity, adults with overweight plus at least one weight-related condition, and certain pediatric patients with obesity 3. Clinical weight-loss results from Saxenda studies apply to that FDA-approved product and studied dose schedule; individual results vary.

Off-label use and why indication matters for coverage

This is why two people using the same active ingredient can see very different insurance answers. A diabetes diagnosis, weight-management diagnosis, cardiovascular-risk indication, or plan exclusion can all change the claim.

Will insurance cover liraglutide?

Insurance coverage for liraglutide depends on your plan, diagnosis, formulary, and whether prior authorization is required. Coverage for type 2 diabetes is often handled differently than coverage for chronic weight management.

Why diagnosis and indication matter

FDA labeling separates Victoza for type 2 diabetes from Saxenda for chronic weight management 2, 3. Your insurer may ask whether the prescription is for diabetes, cardiovascular risk reduction in type 2 diabetes, or weight management.

Prior authorization and formulary tiers

Many plans use formulary tiers, step therapy, quantity limits, or prior authorization for GLP-1 medications. These tools can affect whether the drug is covered, how much you pay, and whether the pharmacy can fill the exact quantity prescribed.

Questions to ask your insurer or pharmacy

• Is liraglutide injection on my formulary?
• Is the covered product brand Victoza, generic liraglutide, Saxenda, or another GLP-1?
• Does my plan require prior authorization?
• Does the plan cover the diagnosis on my prescription?
• What is my copay or coinsurance for the exact pen quantity?
• Are there quantity limits or preferred pharmacies?

Where can you buy generic liraglutide safely?

You should buy generic liraglutide only with a valid prescription from a licensed pharmacy. Avoid websites offering GLP-1 injections without a prescription or clinician review.

Prescription requirements

Liraglutide injection is a prescription medication. FDA labeling includes serious warnings and contraindications, so a clinician should review your health history, medications, and risk factors before use 2, 3.

Retail pharmacies and manufacturer availability

Most patients fill FDA-approved generic or brand liraglutide through retail or mail-order pharmacies. Availability may vary because wholesalers, insurers, and pharmacies do not all stock every product at all times.

How to avoid unsafe online sellers

The safer path is licensed clinician evaluation plus a licensed pharmacy. Be cautious with sellers that skip prescriptions, use vague “research” labels, ship unlabeled injectables, or do not identify a licensed pharmacy.

Is liraglutide stronger than Ozempic?

“Stronger” is not the best way to compare GLP-1 medications. Liraglutide and semaglutide are in the same GLP-1 receptor agonist drug class, but they differ in dose schedule, labeled uses, evidence, side effects, and patient fit.

Liraglutide vs semaglutide: drug class and dosing frequency

Victoza and Saxenda contain liraglutide and are injected once daily 2, 3. Ozempic and Wegovy contain semaglutide and are injected once weekly on their FDA labels 6, 7.

Blood sugar and weight-loss evidence limits

In the STEP 8 randomized trial, once-weekly semaglutide 2.4 mg produced greater mean body-weight reduction than once-daily liraglutide 3.0 mg in adults with overweight or obesity without diabetes; adverse events were mostly gastrointestinal and occurred with both drugs 8. Individual results vary, and this trial does not prove which medication is best for one person.

Why “stronger” is not the same as “better for you”

A medication with more average weight loss in a trial may not be the right fit if side effects, contraindications, cost, access, diagnosis, or goals do not match. GLP-1 medications can cause nausea, vomiting, diarrhea, constipation, gallbladder problems, pancreatitis warnings, and hypoglycemia risk when combined with insulin or sulfonylureas 2, 6.

What GLP-1 options does Chia offer for weight care?

Chia does not list liraglutide as a current treatment. For eligible weight-care patients, Chia currently offers compounded semaglutide injection and compounded tirzepatide tablets or injection through licensed-provider review and US 503A pharmacy fulfillment.

Chia does not list liraglutide as a current treatment

If you are specifically trying to fill a prescription for generic liraglutide, you should use the prescribing clinician and pharmacy path for that medication. At Chia, our current GLP-1-related weight-care catalog is different: semaglutide injection and tirzepatide tablets or injection.

Semaglutide injection at Chia: compounded through a 503A pharmacy

Chia offers compounded semaglutide as an injection, with plans currently starting at $249/month. Dosing is provider-guided and adjusted over time, including microdosing plans where clinically appropriate.

Tirzepatide tablets or injection at Chia, including microdosing plans

Chia offers compounded tirzepatide as tablets starting at $249/month and injection starting at $299/month. Tirzepatide is a dual GIP and GLP-1 receptor agonist; FDA-approved tirzepatide products include Mounjaro for type 2 diabetes and Zepbound for chronic weight management 9, 10.

How clinician review, eligibility, and shipping work

Treatment at Chia is 100% online. You complete a short health questionnaire, a licensed US provider reviews it, and medication is prescribed only where clinically appropriate. If prescribed, compounded medication is prepared by a state-licensed 503A pharmacy and shipped to your door.

When to use the Chia quiz or DoctorMCP access path

You can start with the Chia eligibility quiz. Where supported by your tools, agentic access can also route through DoctorMCP at mcp.chia.health, but a prescription still requires a licensed medical evaluation and is never guaranteed.

What safety warnings should patients know about liraglutide?

Liraglutide safety should be part of any cost decision. A lower price is not useful if the medication is not appropriate for your medical history or current medications.

Boxed warning for thyroid C-cell tumors

Liraglutide labels include a boxed warning about thyroid C-cell tumors. Liraglutide is contraindicated for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 2, 3.

Pancreatitis, gallbladder, kidney, and hypoglycemia warnings

Liraglutide labeling includes warnings about pancreatitis, acute gallbladder disease, kidney injury or worsening renal impairment, serious hypersensitivity reactions, and hypoglycemia when used with insulin or insulin secretagogues such as sulfonylureas 2, 3.

Common gastrointestinal side effects

Common side effects reported with liraglutide include nausea, diarrhea, vomiting, decreased appetite, dyspepsia, and constipation 1. GI side effects are also common across GLP-1 medicines, including semaglutide and tirzepatide products 6, 9.

Who should discuss alternatives with a clinician

• People with a personal or family history of medullary thyroid carcinoma or MEN2.
• People with a history of pancreatitis or significant gallbladder disease.
• People using insulin or sulfonylureas, because hypoglycemia risk may increase.
• People with kidney disease, dehydration risk, or severe vomiting or diarrhea.
• People who are pregnant, planning pregnancy, or breastfeeding should discuss risks and alternatives with a clinician.

How should patients compare liraglutide cost with other GLP-1 options?

Compare monthly GLP-1 cost only after you know the exact product, indication, dose schedule, insurance answer, and safety fit. A cash price can look good but still be the wrong match if coverage, side effects, or goals do not line up.

Comparison table: liraglutide, semaglutide, tirzepatide

FDA-approved brand drugs vs generic drugs vs compounded medications

FDA-approved brand and generic drugs are reviewed by the FDA for their specific products. Compounded medications are prepared for an individual patient by a licensed pharmacy when prescribed by a clinician; they are not FDA-approved and should not be called generic versions of Ozempic, Wegovy, Mounjaro, Zepbound, Victoza, or Saxenda.

What to compare beyond monthly price

• Your medical reason for treatment: type 2 diabetes, chronic weight management, cardiovascular risk, or another clinician-reviewed goal.
• FDA-labeled indication versus off-label use.
• Insurance coverage, prior authorization, quantity limits, and cash price.
• Dose schedule: daily versus weekly, and whether injections or tablets fit your routine.
• Side effects, contraindications, and medication interactions.
• Clinical support: who reviews labs, symptoms, dose changes, and follow-up questions.

At Chia, patients who are considering weight care can also review the Weight + Energy protocol and Weight + Muscle protocol. These are clinician-reviewed protocols for eligible patients and are not substitutes for generic liraglutide.

FAQ: liraglutide generic cost

Keep reading

GLP-1 Medications

Victoza for Weight Loss: How It Works, What to Expect, and Alternatives

Weight Loss

Peptide Supplements for Weight Loss: What Works, What Doesn’t, and What’s Actually Prescribed

GLP-1 Weight Loss

Microdosing GLP-1s vs Standard Doses: What the Evidence Shows